Allianz's Price backs Tesla for European roll-out of Model 3

Electric car boost

clock • 1 min read

Allianz Global Investors' Walter Price has highlighted a "significant moment for the future of electric cars in Europe" is on the horizon as orders open for Tesla's Model 3 saloon car.

Price, who has managed the £528m Allianz Technology investment trust for more than 12 years, said Tesla's latest offering is the cheapest car in its range at $35,000, and has been made possible due to a reduction in relative costs. "As it stands, the battery is around one-third of the cost of the car, but this is falling by 15% every year. At the same time, the cost of meeting environmental regulations for normal cars is increasing by 15% per year," he explained. Megatrends: Understanding the tech revolution "As such, buyers are increasingly asking 'why not?' rather than 'why?' Own...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot